Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
SALT LAKE CITY, May 2, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that its Analyst and Investor Day for research analysts and institutional investors will take place on Thursday, May 9, 2013 at 9:00 a.m. EST in New York City. Peter D. Meldrum, president and chief executive officer of Myriad, will host the event that also will include other key members of Myriad's executive team. The focus of the meeting will be on Myriad's diagnostic product pipeline and the Company's strategic growth initiatives.
Help employers find you! Check out all the jobs and post your resume.
SALT LAKE CITY, May 2, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that its Analyst and Investor Day for research analysts and institutional investors will take place on Thursday, May 9, 2013 at 9:00 a.m. EST in New York City. Peter D. Meldrum, president and chief executive officer of Myriad, will host the event that also will include other key members of Myriad's executive team. The focus of the meeting will be on Myriad's diagnostic product pipeline and the Company's strategic growth initiatives.
Help employers find you! Check out all the jobs and post your resume.
